IGC Pharma (IGS1) Q4 2026 Earnings Report
DE:IGS1 Q4 2026 EPS Results
- Actual EPS
- -EUR 0.02
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.02
DE:IGS1 Q4 2026 Revenue Results
- Actual Revenue
- EUR 283.43K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -3.35%
Earnings Announcement Details
- Quarter
- Q4 2026
- Date
- 06/15/2026
- Time
- TBA
- Conference Call
- Monday, June 15, 2026
DE:IGS1 Upcoming Earnings
IGC Pharma's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q4 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:IGS1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2027 (Q2) | -0.02- | -0.02 | ― | ― |
| Jun 15, 2026 | 2026 (Q4) | ―-0.02 | -0.02 | 0.00% (+0.00) | |
| Mar 19, 2026 | 2026 (Q3) | -0.02-0.01 | -0.02 | 50.00% (+0.01) | |
| Nov 17, 2025 | 2026 (Q2) | -0.02-0.02 | -0.02 | 0.00% (+0.00) | |
| Aug 19, 2025 | 2026 (Q1) | ―- | -0.03 | ― | |
| Jun 30, 2025 | 2025 (Q4) | -0.02-0.02 | -0.03 | 33.33% (+0.01) | |
| Feb 18, 2025 | 2025 (Q3) | -0.03-0.02 | -0.08 | 77.78% (+0.06) | |
| Nov 14, 2024 | 2025 (Q2) | -0.03-0.02 | -0.04 | 60.00% (+0.03) | |
| Aug 09, 2024 | 2025 (Q1) | -0.03-0.03 | -0.03 | 23.08% (+0.01) | |
| Jun 24, 2024 | 2024 (Q4) | -0.04-0.03 | -0.07 | 53.95% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
